hexamethylene bisacetamide has been researched along with azacitidine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kizaki, M; Koeffler, HP | 1 |
| Daksis, JI; McFarlane, M; Preston, CM | 1 |
| Parker, RF; Scott, RE; Wang, H; Witte, MM | 1 |
| Hassan, HT; Maurer, HR; Veit, A | 1 |
| Allalouf, D; Friedman, J; Levinsky, H; Seger, M | 1 |
| Fishman, PH; Kassis, S; Sullivan, M | 1 |
| Anagnou, NP; Anderson, WF; Chiang, YL; Haidaris, D; Ley, TJ; Wilson, VL | 1 |
| Edwards, SW; Hart, CA; Moulding, DA | 1 |
| Ferrini, PR; Santini, V | 1 |
| Andrews, KT; Fairlie, DP; Kelso, MJ; Parsons, PG; Saul, A; Walduck, A | 1 |
| Fang, D; Setaluri, V; Tsuji, Y | 1 |
| Fernández-Nestosa, MJ; Hernández, P; Krimer, DB; Schvartzman, JB | 1 |
| Barat, C; Dental, C; Ouellet, M; Proust, A; Tremblay, MJ | 1 |
2 review(s) available for hexamethylene bisacetamide and azacitidine
| Article | Year |
|---|---|
Differentiation-inducing agents in the treatment of myelodysplastic syndromes.
Topics: Acetamides; Azacitidine; Calcitriol; Drug Therapy, Combination; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1992 |
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
11 other study(ies) available for hexamethylene bisacetamide and azacitidine
| Article | Year |
|---|---|
Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65.
Topics: Acetamides; Animals; Azacitidine; Base Sequence; Cell Line; Dimethyl Sulfoxide; DNA, Viral; Gene Expression Regulation, Viral; HeLa Cells; Hematinics; Humans; Hypoxanthine; Hypoxanthines; Immediate-Early Proteins; Molecular Sequence Data; Mutation; RNA, Viral; Simplexvirus; Time Factors; Trans-Activators; Transcription, Genetic; Viral Proteins; Virus Replication | 1992 |
Repression of SV40 T oncoprotein expression by DMSO.
Topics: Acetamides; Animals; Antigens, Polyomavirus Transforming; Azacitidine; Blotting, Northern; Blotting, Western; Butyrates; Butyric Acid; Cell Line, Transformed; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Insulin; Interferons; Mice; Phenotype; Stem Cells; T-Lymphocytes; Tretinoin | 1992 |
Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
Topics: Acetamides; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Differentiation; Cell Division; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Tretinoin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.
Topics: Acetamides; Azacitidine; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Differentiation; Colonic Neoplasms; Drug Synergism; Formamides; Humans; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Modulation of the beta-adrenergic receptor-coupled adenylate cyclase by chemical inducers of differentiation: effects on beta receptors and the inhibitory regulatory protein Gi.
Topics: Acetamides; Adenylyl Cyclases; Azacitidine; Butyrates; Butyric Acid; Cell Differentiation; Cells, Cultured; Enzyme Induction; GTP-Binding Proteins; HeLa Cells; Humans; Neoplasms, Experimental; Puromycin; Puromycin Aminonucleoside; Receptors, Adrenergic, beta | 1988 |
DNA methylation and regulation of the human beta-globin-like genes in mouse erythroleukemia cells containing human chromosome 11.
Topics: Acetamides; Animals; Azacitidine; Cell Line; Chromosomes, Human, 6-12 and X; DNA; Gene Expression Regulation; Globins; Humans; Hybrid Cells; Leukemia, Erythroblastic, Acute; Methylation; Mice; RNA, Messenger | 1984 |
Modulation of neutrophil apoptosis by pharmacological agents.
Topics: Acetamides; Apoptosis; Azacitidine; Butyrates; Butyric Acid; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Neutrophils; Superoxides | 1996 |
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.
Topics: Acetamides; Animals; Antimalarials; Antineoplastic Agents; Azacitidine; Cell Differentiation; DNA Methylation; Enzyme Inhibitors; Female; Hematinics; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum | 2000 |
Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
Topics: Acetamides; Azacitidine; Binding Sites; Blotting, Northern; Cells, Cultured; Cycloheximide; Decitabine; DNA-Binding Proteins; Down-Regulation; Electrophoretic Mobility Shift Assay; Gene Expression Regulation; Humans; Hydroxamic Acids; Luciferases; Melanocytes; Membrane Glycoproteins; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Mutation; Oxidoreductases; Promoter Regions, Genetic; Protein Binding; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Sequence Deletion; Transcription Factors; Tumor Cells, Cultured | 2002 |
PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Topics: Acetamides; Animals; Azacitidine; Cell Differentiation; Decitabine; Drug Resistance; Erythroid Cells; Friend murine leukemia virus; GATA1 Transcription Factor; Genes, myc; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Proto-Oncogene Proteins; RNA, Small Interfering; Trans-Activators; Tumor Cells, Cultured | 2008 |
HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.
Topics: Acetamides; Azacitidine; Azepines; Blood-Brain Barrier; Bryostatins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CCL2; Cytokines; Decitabine; HIV-1; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Phorbol Esters; Quinazolines; Receptors, Cell Surface; Virus Latency | 2017 |